Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT07047131

Resorbable vs Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants

A Resorbable Versus a Non-resorbable Bone Substitute at Immediate Post-extractive Single Implants Immediately Loaded: a Multicentre Randomised Controlled Trial

Status
Active Not Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Marco Esposito · Network
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study compares two bone graft materials used when placing a dental implant right after tooth removal. One graft fully dissolves (GTO®), the other only partly (Apatos®). The goal is to see which one better preserves bone and improves appearance around the implant.

Detailed description

This multicenter, double-blind randomized controlled trial aims to compare the clinical, radiographic, and aesthetic outcomes of two xenogeneic bone substitutes, GTO® (fully resorbable) and Apatos® (partially resorbable), used in post-extractive sockets at the time of immediate implant placement. Eligible patients are adults requiring a single-tooth extraction in the maxilla or mandible, followed by immediate implant placement. The primary outcome is peri-implant bone volume changes over time, assessed using CBCT scans. Secondary outcomes include implant and crown failure, implant stability, marginal bone level changes on periapical radiographs, and aesthetic outcomes evaluated using the pink esthetic score based on clinical photographs. Patients will be followed up to 5 years after loading.

Conditions

Interventions

TypeNameDescription
BIOLOGICALGTO® (fully resorbable bone substitute)Collagenated heterologous cortico-cancellous porcine bone mix + thermogelling copolymer with collagen (GTO®, OsteoBiol®, Tecnoss®)
BIOLOGICALApatos® (partially resorbable bone substitute)Porcine cortical bone granules (Apatos Cortical®, OsteoBiol®, Tecnoss®) stabilized with TSV Gel®, a thermogelling copolymer with collagen.

Timeline

Start date
2018-12-18
Primary completion
2025-12-20
Completion
2030-12-20
First posted
2025-07-02
Last updated
2025-07-04

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT07047131. Inclusion in this directory is not an endorsement.